Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DKV Seguros wins euro100m hospitals project:

This article was originally published in Clinica

Executive Summary

Hospital development projects worth euro96.64m ($126m) are part of a healthcare services contract secured by Spanish insurance company DKV Seguros and two banks in Spain's Valencia region. Marina Salud, a joint venture between DKV Seguros (the Spanish subsidiary of German insurance company Deutsche Krankenversicherung, part of the ERGO group), Bancaja and Caja de Ahorros del Mediterra neo, will operate the Healthcare Area No 12 of the Comunidad Valenciana region for a period of 15 years, with an option to extend this by a further five. The contract envisages the construction of a hospital in Denia and the refurbishment of two clinics. The new hospital will feature operating theatres, 45 intensive care units, 10 haemodialysis posts and 10 outpatient surgeries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054354

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel